about
Overexpression of CD99 Increases the Migration and Invasiveness of Human Malignant Glioma CellsProteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization.Expression of CD99 in pleomorphic carcinomas of the lung.CD99 expression and newly diagnosed diffuse large B-cell lymphoma treated with rituximab-CHOP immunochemotherapy.Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators.CD99 acts as an oncosuppressor in osteosarcomaImmunoreactivity of CD99 in non-Hodgkin's lymphoma: unexpected frequent expression in ALK-positive anaplastic large cell lymphoma.Human myeloma cell lines induce osteoblast downregulation of CD99 which is involved in osteoblast formation and activity.Downregulation of CD99 and upregulation of human leukocyte antigen class II promote tumor aggravation and poor survival in patients with osteosarcomas.CD99 is upregulated in placenta and astrocytomas with a differential subcellular distribution according to the malignancy stage.CD99 at the crossroads of physiology and pathology.An immunohistochemical study of the expression of adhesion molecules in gallbladder lesions.Myxoid atypical fibroxanthoma: a previously undescribed variant.CD99: A Cell Surface Protein with an Oncojanus Role in Tumors.Immunohistochemical study of the expression of adhesion molecules in ovarian serous neoplasms.CK19 and CD99 Immunoexpression Profile in Goblet Cell (Mucin-Producing Neuroendocrine Tumors) and Classical Carcinoids of the Vermiform Appendix
P2860
Q24610083-C761C6D9-9436-46C1-8CE2-BA1DE2976D56Q33229103-3A726C5A-5188-4265-B7CE-69DEACFDCEF3Q33599373-A7626FB7-DF4D-416D-8B83-3D6817AAA8BAQ34292361-67991808-C9D8-49B2-BCA5-6D09E4F71BC4Q34325539-C651EC79-7EFA-4DCA-A4D7-D35F9DED0DD5Q34483649-A4B74E8D-C8DE-4276-B225-BAD1BC9F8FF9Q37425836-936F068D-C203-4EF7-B251-0145BF7E7AABQ38298890-07B17E5C-1855-4F35-8D6C-9FBF756DA3BFQ38553340-0B9A816E-478C-48D9-8BF4-F72381070101Q38998414-FCAE1376-5BBA-4EEB-8D6B-EF3A55FC47F5Q47203268-CF3A0270-4E36-4D7D-B422-4AA9CCE09225Q47726293-789D3773-383C-43BA-92D2-AC6EAC31B32CQ50453633-9EF390FF-35F9-4656-9BAF-152BA36DCED3Q52658031-7FB5F057-E301-4E39-B509-C8124BA94A29Q53260738-7E710C0B-FA6C-4071-B65F-1456D267B8E1Q57422139-4A697C70-B317-4049-81A1-6353EC813437
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Immunoreactivity of CD99 in stomach cancer
@ast
Immunoreactivity of CD99 in stomach cancer
@en
Immunoreactivity of CD99 in stomach cancer
@nl
type
label
Immunoreactivity of CD99 in stomach cancer
@ast
Immunoreactivity of CD99 in stomach cancer
@en
Immunoreactivity of CD99 in stomach cancer
@nl
prefLabel
Immunoreactivity of CD99 in stomach cancer
@ast
Immunoreactivity of CD99 in stomach cancer
@en
Immunoreactivity of CD99 in stomach cancer
@nl
P2093
P1476
Immunoreactivity of CD99 in stomach cancer
@en
P2093
Hae Wan Lee
Hai-Jeong Shin
Hansoo Lee
Hyung Sik Shin
Hyung-Jin Koo
Jang-Hee Hahn
Kyeong Cheon Jung
Kyuhyoung Hahn
Seong Hoe Park
Weon Seo Park
P356
10.3346/JKMS.2002.17.4.483
P407
P577
2002-08-01T00:00:00Z